Abstract
Recently, a significant improvement in treatment outcomes throughout hematologic malignancies has been achieved. Innovative treatment approaches require new modalities of supportive care.
In this article, we review common requirements on supportive care in oncology and hematopoietic cell transplantation and elucidate the reasoning of this treatment. Due to similar organ affection as in patients after high-dose chemotherapy, we also find possibilities of applying these procedures in patients after high-dose external irradiation.
Further, we describe new requirements on supportive care in hematology. Our aim is to increase the general knowledge about severe immune suppression and specific complications in these patients, which can be useful throughout internal medicine and surgery disciplines.